Objective — To determine the pharmacokinetic and pharmacodynamic dose-response effects of insulin glargine administered subcutaneously in individuals with type 2 diabetes. Research design and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback